Amidst Washington's bruising battles over Medicare and Medicaid reform, one of the few ideas that still enjoys broad bipartisan sup- port is comparative effectiveness research. CER is designed to compare drugs, medical devices or surgeries and determine which treatment offers the best outcome for the greatest number of patients. The hope is that, used effectively, CER will help public (and eventually private) insurers slash spending without harming patient care.
Continue reading . . .